The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

The bio­phar­ma in­dus­try has been a bi­par­ti­san po­lit­i­cal tar­get in re­cent years. But in the 2024 pres­i­den­tial elec­tion, de­tails are scarce around key is­sues that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER